The Chinese Consume...
Health Care: Drugs
Generex Biotechnology Corporation (GNBT: OTC)
$0.16 -0.01 | -4.42%
02/09/12 - 03:59 PM ET
1.07M / 1.97M
Vol / Avg. Vol:0.17 / 0.17
Open / Prev. Close:0.16 - 0.17
Today's Range:0.08 - 0.33
52 Wk Range:13.00%
Performance YTD:TheStreet Rating:
Portfolios with GNBT
- Portfolio NameUser Type
- Userroy
- Userphospho
- Userjetpilot Portfolio 1
- UserEmerging biotech
- Userpdehenau Portfolio 1
- Usernvoelz Portfolio 1
- UserCER777 Portfolio 1
- UserDoc's Picks
- Usermy pikz
- Userterri cal
Latest GNBT Headlines from TheStreet
- Biotech Stock Mailbag: Generex 10.01.10 | 07:10 am
- Generex Oncology Announces Consultancy Of Dr. George E. Peoples, MD 09.02.10 | 09:09 am
- Generex Biotechnology Initiates Social Media Campaign For Its Corporate And E-Commerce Websites 09.01.10 | 09:09 am
- Generex Informs Stockholders Of Minimum Exchange Ratio For Reverse Stock Split Proposal To Be Considered At The Special Meeting Of Stockholders On September 17, 2010 08.27.10 | 04:08 pm
- Generex Oncology Names Dr. Craig Eagle To Its Scientific Advisory Board To Assist With Its Proprietary Cancer Vaccines Program 08.05.10 | 09:08 am
- Generex Biotechnology Creates Scientific Advisory Board To Further The Progression Of Its Drug Development Programs 08.02.10 | 09:08 am
- Generex Announces AGM Results 07.30.10 | 04:07 pm
- Generex Provides Positive Update On Generex Oral-Lyn(TM) Pivotal Phase III Trial 07.28.10 | 09:07 am
- Generex's Glucose RapidSpray(TM) Now Available At Boots UK Retail Chain Stores 07.15.10 | 09:07 am
- Generex Announces Receipt Of Favorable NASDAQ Listing Determination 07.15.10 | 07:07 am
Press Releases for GNBT
- Generex Announces Patent Award For Its Core Vaccine Technologies In Japan - PR Newswire 02.01.12 | 08:02 am
- Generex Announces $2.00 Million Capital Investment - PR Newswire 01.31.12 | 05:01 pm
- Generex Secures Commitments For $3.6M Capital Raise - PR Newswire 01.25.12 | 09:01 am
- Generex Subsidiary Antigen Express Available For Partnering & Collaboration Meetings At The 2012 JPMorgan Healthcare Conference - PR Newswire 01.05.12 | 09:01 am
- Generex Subsidiary Antigen Express Available For Partnering & Collaboration Meetings At The 2012 JPMorgan Healthcare Conference - PR Newswire 01.04.12 | 01:01 pm
- Generex Subsidiary Antigen Express Provides Update On AE37 Cancer Vaccine's Clinical & Regulatory Strategy - PR Newswire 01.03.12 | 09:01 am
- Generex Announces Airing Of Antigen Express Breast Cancer Vaccine Segment On Bloomberg Television - PR Newswire 12.21.11 | 09:12 am
- Generex Provides Update On Bloomberg TV Breast Cancer Vaccine Segment - PR Newswire 12.20.11 | 10:12 am
- Breast Cancer Vaccine Being Developed By Generex Subsidiary Antigen Express To Be Featured On Bloomberg Television Today - PR Newswire 12.19.11 | 09:12 am
- Breast Cancer Vaccine Being Developed By Generex Subsidiary Antigen Express To Be Featured On Bloomberg Television - PR Newswire 12.14.11 | 09:12 am
Partner Headlines for GNBT
- Generex Announces Sales Agreement with Elias Shaker & Company (GNBT) - Benzinga 09.20.10 | 09:09 am
- Good News for Generex: Positive Data on Oral Insulin Coming in September - Seeking Alpha 08.16.10 | 08:08 am
- Generex: Reverse Split Not Approved - Seeking Alpha 08.01.10 | 08:08 am
- Four Small Caps for Binary Event Investors - Seeking Alpha 05.24.10 | 03:05 am
- Why Biodel is Breathing Easy, Part 2 - Seeking Alpha 05.03.10 | 05:05 pm
- Why Biodel is Breathing Easy, Part 1 - Seeking Alpha 05.03.10 | 05:05 pm
- Generex's Insulin Product: When a Company Misrepresents 'Compassionate Use' - SeekingAlpha.com 04.29.10 | 11:04 am
- Generex's Antigen Express: Creating the Next Generation of Cancer Immunotherapy - SeekingAlpha.com 04.14.10 | 04:04 am
- Tengion's IPO Comes In Well Below Initial Range: Biotech's Latest Deals, Financings - SeekingAlpha.com 04.11.10 | 08:04 am
- FDA Concerned About Forest Labs Drug: Biotech's Latest Missed Targets, Mishaps - SeekingAlpha.com 04.11.10 | 07:04 am
